Furthermore, we observed an enduring antitumor response of CB CD8+ T cells, evident by MHC-dependent tumor reactivity that continued to surpass the levels of paired tumor- and PBMC-derived populations after rounds of restimulation in the assay (Fig. 3d). The gene discussed is CD8A; the disease is neoplasm.